SCHEMBL2490477

SCHEMBL2490477

NC(=O)c1cccnc1N1CCCCCN1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP3A4 P08684 1/20 0.41
PARP1 P09874 3/20 0.40
ALDH1A1 P00352 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SCN10A Q9Y5Y9 1/20 0.38
KDM4E B2RXH2 1/20 0.38
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28189129 0.80 KMT2A (0.60) NPC1KMT2AMEN1CYP1A2CYP2C9
SCHEMBL16339825 0.79 GRIN1 (0.42) CYP1A2CYP2C9CYP2C19L3MBTL1KDM4E
SCHEMBL1068235 0.78 SIRT2 (0.35) NPC1TSHR
SCHEMBL883905 0.78 KMT2A (0.58) NPC1KMT2AMEN1CYP1A2CYP2C9
SCHEMBL4538970 0.77 EPHX2 (0.52) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL30945091 0.77 EPHX2 (0.52) KMT2AMEN1CYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL5901187 0.76 EPHX2 (0.51) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL2490475 0.73 SIRT3 (0.42) NPC1KMT2AMEN1ALDH1A1HSD17B10
SCHEMBL2490935 0.72 KDM4E (0.43) ALDH1A1KDM4E
SCHEMBL22291207 0.72 IKBKB (0.51) ALDH1A1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3856183-A1 alfa2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA Bayer Aktiengesellschaft (DE) 2021-08-04 EP claimed
WO-2020064479-A1 α2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA BAYER AKTIENGESELLSCHAFT (DE) 2020-04-02 WO claimed
EP-2364303-A1 ARYL PIPERAZINE AND THEIR USE AS ALPHA2C ANTAGONISTS Orion Corporation (FI) 2011-09-14 EP claimed
WO-2010058060-A1 ARYL PIPERAZINE AND THEIR USE AS ALPHA2C ANTAGONISTS ORION CORPORATION (FI) 2010-05-27 WO claimed
EP-3856183-A1 alfa2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA Bayer Aktiengesellschaft (DE) 2021-08-04 EP disclosed
WO-2020064479-A1 α2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA BAYER AKTIENGESELLSCHAFT (DE) 2020-04-02 WO disclosed
EP-2364303-A1 ARYL PIPERAZINE AND THEIR USE AS ALPHA2C ANTAGONISTS Orion Corporation (FI) 2011-09-14 EP disclosed
WO-2010058060-A1 ARYL PIPERAZINE AND THEIR USE AS ALPHA2C ANTAGONISTS ORION CORPORATION (FI) 2010-05-27 WO disclosed